- Home
- ANIK vs PRQR Comparison
ANIK vs PRQR Comparison
Compare ANIK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIK | PRQR |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.4M | 167.5M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ANIK | PRQR |
|---|---|---|
| Price | $14.26 | $1.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $17.00 | $7.67 |
| AVG Volume (30 Days) | 131.9K | ★ 273.3K |
| Earning Date | 05-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $112,819,000.00 | N/A |
| Revenue This Year | $5.98 | $18.88 |
| Revenue Next Year | $7.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.90 | $1.08 |
| 52 Week High | $15.79 | $3.10 |
Technical Indicators
Market Signals| Indicator | ANIK | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 42.84 |
| Support Level | $9.08 | $1.33 |
| Resistance Level | $15.01 | $1.58 |
| Average True Range (ATR) | 0.51 | 0.11 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 42.75 | 8.16 |
Price Performance
Historical ComparisonAbout ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.